Biogenicskorea Co., Ltd.
Company Profile
Biogenicskorea is the nation's first postbiotics company holding lactobacillus plantarum nF1 strain which is developed kimchi-derived vegetable lactobacillus. We have Korean, US and numuorus patents for technology and efficacy of nF1 strain. We are a manufacturer and distributor of various product divisions as using the strain. We currently supplies heat-treated lactobacillus nF1 to F&B compnay and pharmaceuticals like Chongkeundang healthcare, Seoulmilk and Handok. We launched next-generation lactobacillus postbiotics series, our own brand "GraBio".
Company History
| January, 2020 | Launched lactobacillus postbiotics series, GraBio postbiotics |
|---|---|
| January, 2018 | Commenced supply of nF1 for Seoul Milk Selling nF1 contained HMR(Home Meal Replacement) on Seven Eleven, GS25 Business consultation with Gwangdong Pharma, Crown, SoonsooBon etc |
| January, 2017 | Commenced supply of raw ingredient nF1 for Purmil(N-1), Namyang Dairy Product(Bulgaris lactobacillus Water, Yoguri Mong) Registered a technical patent on Nano-Sized lactobacillus in the United States Acquired the certification labeling required to export to China (nF1, Kimchi lactobacillus series, lactobacillus drinks) Corporate R&D Center recognized |
| January, 2016 | Developed health functional beverage designed to enhance immunity and to improve intestinal health, nano-type kimchi lactobacillus composite, health functional food and confectionery and registered relevant patents accordingly Acquired ISO9001: 2008 Certification Made commercial launch of "Kimchi lactobacillus 5000" and "Organic Maqui Berry" |
| January, 2015 | Registered a technical patent on “Lactobacillus with the capacity of producing and inducing IL-12 and its manufacturing method thereof” Launched 『Kimchi lactobacillus 2000』 |
| January, 2014 | Selected for 2014 Foond Functionality Evaluation Support Project (Ministry of Agriculture, Food and Rural Affairs) |
| January, 2013 | Established Biogenics Korea Co., Ltd. Patent application for “Nano-type kimchi lactobacillus“ pending Patent application for “Lactobacillus with the capacity of producing and inducing IL-12 and its manufacturing method thereof” pending Launched 『Kimchi lactobacillus 1000』 『Kimchi lactobacillus 3000』 |
| January, 2012 | “Prevention of colitis of nF1 using a mouse and colorectal environment improvement activity test” (National Center of Efficacy Evaluation for the Development of Health Products Targeting Digestive Disorders, NCEED) |
| January, 2011 | Doctor of Agriculture Gan Tatsuhiko’s thesis “The era of Biogenics-the beginning of clarifying the true mechanism of lactobacillus “ |
| January, 2008 | Successfully developed kimchi-derived vegetable lactobacillus : World’s first nanonized lactobacillus(nF1) Established Biogenics Liaison Council (Japan) Doctor of Agriculture Gan Tatsuhiko’s thesis “Longevity immunity and lactobacillus: The efficacy of nanonized lactobacillus that induces Th1 cell“ |
| June, 2007 | Successfully developed the technology that cultivates kimchi-derived vegetable lactobacillus into ultrafine Lactobacillus Plantarum and named it nF1 |
Factory / Branch Office
Biogenicskorea Co., Ltd. (www.biogenicskorea.com)
-
The person in charge
Jae Won Kim -
Telephone
82-7048141749 -
Fax
82-25616053 -
Address
315 Gangnam-daero, Seocho-gu, Seoul (06628)
| Business Type | Manufacturer |
|---|---|
| Main Product | VitaC300, Gentinol200 New, EGCG200 |
| Established | 2011-02-09 |
| Total Annual Revenue | 5~6 billion (KRW) |
| Total Employees | 11~50 people |